ImmuPharma PLC CEO Dimitri Dimitriou had an excellent day on 28 November as his daughter got married and the UK biotech signed a deal for Lupuzor with the US's Avion Pharmaceuticals LLC that has breathed new life into the prospects for the investigational lupus drug.
Interview: Double Delight For ImmuPharma's Dimitriou
UK Biotech On The Up
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.
